Education
About Us
Working with TipRanks
Follow Us
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
4512 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥209.00 - ¥377.00
Previous CloseN/A
Volume100.70K
Average Volume (3M)260.88K
Market Cap
¥10.55B
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.56B
Total Debt (Recent Filing)¥100.00M
Price to Earnings (P/E)163.7
Beta0.22
Next Earnings
Aug 01, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield0.99%
Share Statistics
EPS (TTM)2.40
Shares Outstanding34,838,326
10 Day Avg. Volume142,850
30 Day Avg. Volume260,876
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
4512 FAQ
What was Wakamoto Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Wakamoto Pharmaceutical Co., Ltd. lowest stock price was ¥209.00 and its highest was ¥377.00 in the past 12 months.
What is Wakamoto Pharmaceutical Co., Ltd.’s market cap?
Wakamoto Pharmaceutical Co., Ltd.’s market cap is ¥10.55B.
When is Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Wakamoto Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 01, 2025 which is in 49 days.
How were Wakamoto Pharmaceutical Co., Ltd.’s earnings last quarter?
Wakamoto Pharmaceutical Co., Ltd. released its earnings results on May 15, 2025. The company reported ¥2.4 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.4.
Is Wakamoto Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Wakamoto Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Wakamoto Pharmaceutical Co., Ltd. pay dividends?
Wakamoto Pharmaceutical Co., Ltd. pays a Annually dividend of ¥3 which represents an annual dividend yield of 0.99%. See more information on Wakamoto Pharmaceutical Co., Ltd. dividends here
What is Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate?
Wakamoto Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wakamoto Pharmaceutical Co., Ltd. have?
Wakamoto Pharmaceutical Co., Ltd. has 34,838,326 shares outstanding.
What happened to Wakamoto Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Wakamoto Pharmaceutical Co., Ltd. reported an EPS of ¥2.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.971%.
Which hedge fund is a major shareholder of Wakamoto Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4512
Company Description
Wakamoto Pharmaceutical Co., Ltd.
Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Technical Analysis
Morishita Jintan Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
Nippon Chemiphar Co., Ltd.
―
Taiko Pharmaceutical Co., Ltd.
―
Symbio Pharmaceuticals Limited
―